[1] 国家肿瘤质控中心乳腺癌专家委员会.中国乳腺癌规范诊疗质量控制指标(2022版)[J]. 中华肿瘤杂志,2022,44(3):203-208. [2] 国家肿瘤质控中心乳腺癌专家委员会,中国抗癌协会乳腺癌专业委员会,中国抗癌协会肿瘤药物临床研究专业委员会. 中国晚期乳腺癌规范诊疗指南(2020版)[J]. 中华肿瘤杂志,2020,42(10):781-797. [3] 中华人民共和国国家卫生健康委员会.乳腺癌诊疗指南(2022年版)[J].中国合理用药探索,2022,19(10):1-26. [4] Mayer EL, Dueck AC, Martin M, et al.Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): Interim analysis of a multicentre, open-label, randomised, phase 3 study[J].Lancet Oncol,2021,22(2):212-222. [5] 张宏艳,徐蕾.乳腺癌生存者的管理——循证而行[J].医学与哲学,2017,38(16):60-63,83. [6] 潘宸,杨林宁,杨艳.乳腺癌患者健康信息需求的研究进展[J].中华护理杂志,2022,57(20):2547-2554. [7] 闫婷婷,乔婷婷,郑蔚,等.中文版癌症患者未满足需求简明量表的信效度研究[J].现代预防医学,2018,45(2):308-313. [8] 郑粉善,曹沛莹,华兴龙,等.乳腺癌患者需求量表的编制及信效度检验[J].中华护理杂志,2022,57(4):469-475. [9] 国家卫生计生委办公厅,国家中医药管理局办公室.乳腺癌分级诊疗服务技术方案[EB/OL].(2017-02-09)[2022-12-22].http://www.nhc.gov.cn/yzygj/s3594q/201702/0c46c23dc26949 73bb5bea8060f1ccff.shtml. [10] 中国健康教育中心.健康教育处方(2020年版)[EB/OL]. (2020-08-21)[2022-12-22]. http://www.nhc.gov.cn/xcs/s3582/202008/d6cd89437cb14f58b32c7ce8b48efa61.shtml. [11] Carreira H, Williams R, Müller M, et al.Associations between breast cancer survivorship and adverse mental health outcomes: A systematic review[J].J Natl Cancer Inst,2018,110(12):1311-1327. [12] 杨艳玲,王伟洪,陆关珍,等.乳腺癌幸存者未满足需求研究进展[J].齐鲁护理杂志,2019,25(20):93-96. [13] Ho PJ, Gernaat SAM, Hartman M, et al.Health-related quality of life in Asian patients with breast cancer:A systematic review[J].BMJ Open,2018,8(4):e020512. [14] 陈玉恒,赵全年,宋力,等. 乳腺癌患者对“互联网+”康复健康教育的认知调查分析[J]. 中国肿瘤临床与康复,2020,27(9):1037-1040. [15] Huynh V, Vemuru S, Hampanda K, et al.No one-size-fits-All: Sexual health education preferences in patients with breast cancer[J].Ann Surg Oncol,2022,29(10):6238-6251. [16] Badger TA, Sikorskii A, Segrin C, et al.Supportive health education reduces health care utilization and costs in Latinas with breast cancer and their caregivers[J].Support Care Cancer,2021,29(3):1225-1233. [17] Khapre M, Ravi B, Sharda P, et al.Evaluation of an interventional health education project: Screening of breast cancer and health education (SHE)[J].Asian Pac J Cancer Prev,2022,23(7):2361-2366. |